Compare AGRO & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRO | ENOV |
|---|---|---|
| Founded | 2002 | 1995 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Fluid Controls |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2011 | 2008 |
| Metric | AGRO | ENOV |
|---|---|---|
| Price | $9.17 | $24.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $12.80 | ★ $47.38 |
| AVG Volume (30 Days) | 661.3K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $45.90 | $6.36 |
| Revenue Next Year | N/A | $5.31 |
| P/E Ratio | $37.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.89 | $19.14 |
| 52 Week High | $15.89 | $34.28 |
| Indicator | AGRO | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 42.97 |
| Support Level | $9.04 | $21.02 |
| Resistance Level | $9.24 | $27.51 |
| Average True Range (ATR) | 0.38 | 1.49 |
| MACD | -0.05 | -0.75 |
| Stochastic Oscillator | 10.27 | 10.63 |
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.